Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 50Brain Neoplasms 15Lung Neoplasms 8Melanoma 7Carcinoma, Non-Small-Cell Lung 7Triple Negative Breast Neoplasms 5Prostatic Neoplasms 5Neoplasm Metastasis 5Carcinoma, Renal Cell 4Breast Neoplasms, Male 4Gastrointestinal Neoplasms 3Early Stage Breast Cancer 3Colorectal Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma 2Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Lymphatic Metastasis 1Kidney Neoplasms 1HR-positive,HER2-negative Breast Cancer 1Colonic Neoplasms 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1

Interventions

trastuzumab deruxtecan 2neratinib 1Radiosurgery 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer With Brain Metastasis × Radiosurgery × Breast × Clear all
NCT01924351 2020-03-18

HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)

University of Maryland, Baltimore

Phase 2 Withdrawn
Breast

Breast Cancer With Brain Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡